American International Group’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

American International Group’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-15,159	Closed	-$317K	–	3038
2016 Q3	$317K	Buy	15,159 +23	+0.2%	+$265	﹤0.01%	1875
2016 Q2	$163K	Buy	15,136 +7,368	+95%	+$63K	﹤0.01%	2277
2016 Q1	$52K	Hold	7,768	–	–	﹤0.01%	3870
2015 Q4	$141K	Sell	7,768 -14	-0.2%	-$193	﹤0.01%	3184
2015 Q3	$86K	Buy	7,782 +9	+0.1%	+$96	﹤0.01%	3596
2015 Q2	$112K	Buy	7,773 +4,245	+120%	+$57.6K	﹤0.01%	3593
2015 Q1	$41.3K	Hold	3,528	–	–	﹤0.01%	4065
2014 Q4	$58.7K	Buy	+3,528	New	+$51.6K	﹤0.01%	3893

American International Group's VTAE Position: Q4 2016 in Review

American International Group sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 15,159 shares — an estimated $317K sold.

American International Group first reported a position in VTAE in Q4 2014 and held it in 8 quarters. The position peaked at $317K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

American International Group reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
American International Group sold 15,159 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $317K.
American International Group first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 8 quarters.
American International Group's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $317K in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on American International Group's 13F filing for Q4 2016, filed 10 Feb 2017.